{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:57:48Z","timestamp":1778857068512,"version":"3.51.4"},"reference-count":16,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Polish Lymphoma Research Group","award":["ML19931"],"award-info":[{"award-number":["ML19931"]}]},{"name":"Roche Polska Sp. z o.o"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>R\u2010CVP (cyclophosphamide, vincristine, prednisone) and R\u2010CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone + rituximab) are immunochemotherapy regimens frequently used for remission induction of indolent non\u2010Hodgkin lymphomas (iNHLs). Rituximab maintenance (RM) significantly improves progression\u2010free survival (PFS) in patients with complete\/partial remission (CR\/PR). Here we report the final results of a randomized study comparing R\u2010CVP to R\u2010CHOP both followed by RM. Untreated patients in need of systemic therapy with symptomatic and progressive iNHLs including follicular (FL) and marginal zone lymphoma (MZL), mucosa\u2010associated lymphoid tissue (MALT), small lymphocytic (SLL), and lymphoplasmacytic (LPL) lymphoma were eligible. Patients were randomized to receive R\u2010CVP or R\u2010CHOP for eight cycles or until complete response (CR). All patients with CR\/PR (partial response) received RM 375\u00a0mg\/m<jats:sup>2<\/jats:sup> q 2\u00a0months for 12 cycles. Primary endpoint was event\u2010free survival (EFS). Two\u2010hundred and fifty patients [FL 42%, MZL\/MALT 38%, LPL\/ Waldenstr\u00f6m Macroglobulinaemia (WM) 11%, SLL 9%] were enrolled and randomized (R\u2010CHOP: 127, R\u2010CVP: 123). Median age was 56\u00a0years (21\u201385), 44% were male, 90% were in stage III\u2013IV, 43% of FL patients had a Follicular Lymphoma International Prognostic Index (FLIPI) score \u22653, and 33\u00b74% of all patients had an IPI score \u22653. At the end of induction treatment, the CR\/PR rate was 43\u00b76\/50\u00b79% and 36\u00b73\/60\u00b78% in the R\u2010CHOP and R\u2010CVP groups (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7218) respectively. After a median follow\u2010up of 67, 66, and 70\u00a0months, five\u2010year EFS was 61% vs. 56% (not significant), progression\u2010free survival (PFS) was 71% vs. 69% (not significant) and overall survival (OS) was 84% vs. 89% in the R\u2010CHOP vs. the R\u2010CVP arm respectively. Grade III\/IV adverse events (65 vs. 22) occurred in 40 (33\u00b71%) and 18 (15\u00b73%) patients, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7001; neutropenia in 16 (11\u00b76%) and 4 (3\u00b74%) patients, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7017; infection in 14 (10\u00b77%) and 3 (2\u00b75%) patients,; <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7011; and a second neoplasm in three <jats:italic>versus<\/jats:italic> seven patients., in the R\u2010CHOP and the R\u2010CVP groups respectively. This multicentre randomized study with &gt;five\u2010year follow\u2010up shows similar outcome in patients with indolent lymphoma in need of systemic therapy treated with R\u2010CVP or R\u2010CHOP immunochemotherapy and rituximab maintenance in both arms. The minor toxicity of the R\u2010CVP regimen makes it a reasonable choice for induction treatment, leaving other active agents like doxorubicin or bendamustin for second\u2010line therapy.<\/jats:p>","DOI":"10.1111\/bjh.16264","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T01:59:07Z","timestamp":1575338347000},"page":"898-906","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["First\u2010line R\u2010CVP <i>versus<\/i> R\u2010CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4"],"prefix":"10.1111","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-2674","authenticated-orcid":false,"given":"Jan","family":"Walewski","sequence":"first","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Paszkiewicz\u2010Kozik","sequence":"additional","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Michalski","sequence":"additional","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Rymkiewicz","sequence":"additional","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Szpila","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Transfusiology Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Butrym","sequence":"additional","affiliation":[{"name":"Medical University Wroclaw Wroclaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Giza","sequence":"additional","affiliation":[{"name":"Jagiellonian University Collegium Medicum Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan M.","family":"Zaucha","sequence":"additional","affiliation":[{"name":"Medical University Gdansk Gdansk Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Kalinka\u2010Warzocha","sequence":"additional","affiliation":[{"name":"Polish Mother's Memorial Hospital \u2013 Research Institute Lodz Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Wieczorkiewicz","sequence":"additional","affiliation":[{"name":"Silesian Medical University Katowice Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmara","family":"Zimowska\u2010Cury\u0142o","sequence":"additional","affiliation":[{"name":"Medical University Wroclaw Wroclaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Knopi\u0144ska\u2010Pos\u0142uszny","sequence":"additional","affiliation":[{"name":"Maritime Hospital Gdynia Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Tyczy\u0144ska","sequence":"additional","affiliation":[{"name":"Maritime Hospital Gdynia Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Romejko\u2010Jarosi\u0144ska","sequence":"additional","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"D\u0105browska\u2010Iwanicka","sequence":"additional","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Gruszecka","sequence":"additional","affiliation":[{"name":"Lower Silesia Cell Transplantation Center Wroclaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jamrozek\u2010Jedli\u0144ska","sequence":"additional","affiliation":[{"name":"Municipal Hospital Poznan Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Borawska","sequence":"additional","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Ho\u0142da","sequence":"additional","affiliation":[{"name":"Subcarpathian Voivodeship Hospital Krosno Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Porowska","sequence":"additional","affiliation":[{"name":"Central Clinical Hospital of the MSWiA Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Romanowicz","sequence":"additional","affiliation":[{"name":"Central Clinical Hospital of the MSWiA Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Hellmann","sequence":"additional","affiliation":[{"name":"Medical University Gdansk Gdansk Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Stella\u2010Ho\u0142owiecka","sequence":"additional","affiliation":[{"name":"Silesian Medical University Katowice Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Depta\u0142a","sequence":"additional","affiliation":[{"name":"Central Clinical Hospital of the MSWiA Warsaw Poland"},{"name":"Medical University of Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Jurczak","sequence":"additional","affiliation":[{"name":"Maria Sklodowska\u2010Curie Institute \u2013 Oncology Center in Warsaw Warsaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.082412"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx189"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.0866"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0016"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8960"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.1652"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018017673"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3175"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.5376"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805104"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28659"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62175-7"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.16264","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.16264","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.16264","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.16264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T21:09:57Z","timestamp":1694034597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.16264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1111\/bjh.16264"],"URL":"https:\/\/doi.org\/10.1111\/bjh.16264","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"2019-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}